74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Afya Ltd (Class A)
Closed
Sector Consumer defensive
17.34 -0.63
Overview
Share price change
24h
Min
17.26
Max
17.38
Income | -29M 137M |
|---|---|
Sales | 31M 841M |
P/E Sector Avg | 15.973 44.075 |
EPS | 1.79 |
Profit margin | 16.236 |
EBITDA | 32M 316M |
Recommendations | Strong Sell |
|---|---|
12 Months Forecast | -13.54 downside |
Next Earnings | 13 Mar 2025 |
|---|
Market Cap | 1.6B |
|---|---|
Previous open | 17.97 |
Previous close | 17.34 |
News Sentiment
By Acuity
50%
50%
62 / 154 Consumer defensive
Technical Score
By Trading Central
Confidence
Bullish Evidence
Afya Ltd (Class A) Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Afya Ltd (Class A) Forecast
Price Target
By TipRanks
-13.54% downside
12 Months Forecast
Average 15 USD -13.54%
High 16 USD
Low 14 USD
Based on 3 Wall Street analysts offering 12 month price targets forAfya Ltd (Class A) - Dist in the last 3 months.
Sentiment
By Acuity
62 / 154 Consumer defensive
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Afya Ltd (Class A)
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
